Last week I represented JANE-2 on a panel discussion organized by the EUonQol project. Discussions focused on the importance of synergies and collaboration across EU projects and initiatives, on an important topic in #oncology: #qualityoflife (QoL).

🔗 jane-2.eu
🔗 euonqol.eu

#science #healthpolicy

Effective #healthpolicy is built on solid evidence, especially clinical evidence.

Experts from EU #regulatory agencies, including the EMA, have highlighted 6 principles for #clinicalevidence generation in line with their vision for 2030.

Article 🔗: ascpt.onlinelibrary.wiley.com/doi/full/10....

The WHO's Datadot project, or its one-stop shop for #healthdata, has finally been populated with data from various WHO Member States.

This is an incredible repository of data and should be bookmarked by everyone who is interested in understanding #globalhealth disparities.

data.who.int/countries

Our new publication on #HealthNetworking on #cancer in the European Union.

These “[Networks of Expertise], […], hold the promise of creating a new way of providing high-quality care to all patients with cancer in the EU, at least in some cancer care areas.”

🔗 www.sciencedirect.com/science/arti...

“Most [essential] #medicines failed to reach the WHO target of 80% availability, and a month's supply cost of less than a day's wage of the lowest-paid government worker. This inequity constitutes an important violation of human rights and demands urgent […] action.”
A must-read: bit.ly/4fBaeAN

The EU’s first legislation on Health Technology Assessment, the #HTA Regulation, will become fully applicable across the EU27 in just over a month. #Cancer medicines will be prioritized for the first few years, along with #ATMPs. What do you need to know to be ready for this? Take a look👇: